NINGBO SANXING MEDICAL ELECTRIC CO.,LTD. Financials Ningbo Sanxing Medical Electric Co.,Ltd.
Equities
601567
CNE100001567
Electrical Components & Equipment
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.3 CNY | +1.63% |
|
-5.25% | +67.32% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 9,221 | 22,615 | 18,980 | 28,947 | 48,404 | - | - |
| Enterprise Value (EV) 1 | 9,221 | 22,615 | 18,980 | 28,947 | 48,404 | 48,404 | 48,404 |
| P/E ratio | 9.64 x | 32.6 x | 20.1 x | 15.2 x | 21 x | 17.6 x | 13.9 x |
| Yield | - | - | - | 3.17% | 2.33% | 2.81% | 3.59% |
| Capitalization / Revenue | - | 3.22 x | 2.09 x | 2.53 x | 3.42 x | 2.85 x | 2.39 x |
| EV / Revenue | - | 3.22 x | 2.09 x | 2.53 x | 3.42 x | 2.85 x | 2.39 x |
| EV / EBITDA | - | 21.2 x | 13.4 x | 11.2 x | 14.1 x | 12.9 x | - |
| EV / FCF | - | - | - | 21.5 x | 44.7 x | 21.5 x | 16.6 x |
| FCF Yield | - | - | - | 4.66% | 2.24% | 4.66% | 6.02% |
| Price to Book | - | 2.55 x | 2 x | 2.63 x | 3.89 x | 3.38 x | 3.02 x |
| Nbr of stocks (in thousands) | 1,386,569 | 1,386,569 | 1,407,977 | 1,412,070 | 1,411,197 | - | - |
| Reference price 2 | 6.650 | 16.31 | 13.48 | 20.50 | 34.30 | 34.30 | 34.30 |
| Announcement Date | 4/19/21 | 4/25/22 | 4/26/23 | 4/25/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 7,023 | 9,098 | 11,463 | 14,170 | 16,970 | 20,234 |
| EBITDA 1 | - | 1,068 | 1,415 | 2,578 | 3,444 | 3,752 | - |
| EBIT 1 | - | 851.2 | 1,152 | 2,270 | 2,750 | 3,322 | 4,140 |
| Operating Margin | - | 12.12% | 12.67% | 19.81% | 19.41% | 19.58% | 20.46% |
| Earnings before Tax (EBT) 1 | - | 846.8 | 1,152 | 2,262 | 2,749 | 3,321 | 4,137 |
| Net income 1 | 956.1 | 690 | 948.1 | 1,904 | 2,308 | 2,760 | 3,470 |
| Net margin | - | 9.83% | 10.42% | 16.61% | 16.29% | 16.26% | 17.15% |
| EPS 2 | 0.6900 | 0.5000 | 0.6700 | 1.350 | 1.637 | 1.954 | 2.460 |
| Free Cash Flow 1 | - | - | - | 1,348 | 1,082 | 2,256 | 2,916 |
| FCF margin | - | - | - | 11.76% | 7.64% | 13.29% | 14.41% |
| FCF Conversion (EBITDA) | - | - | - | 52.3% | 31.42% | 60.12% | - |
| FCF Conversion (Net income) | - | - | - | 70.82% | 46.88% | 81.75% | 84.05% |
| Dividend per Share 2 | - | - | - | 0.6500 | 0.8000 | 0.9633 | 1.230 |
| Announcement Date | 4/19/21 | 4/25/22 | 4/26/23 | 4/25/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2024 Q1 |
|---|---|
| Net sales | - |
| EBITDA | - |
| EBIT | - |
| Operating Margin | - |
| Earnings before Tax (EBT) | - |
| Net income 1 | 364.3 |
| Net margin | - |
| EPS 2 | 0.2600 |
| Dividend per Share | - |
| Announcement Date | 4/25/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | - | 1,348 | 1,082 | 2,256 | 2,916 |
| ROE (net income / shareholders' equity) | - | 7.9% | 10.3% | 18.5% | 19.4% | 19.9% | 22.6% |
| ROA (Net income/ Total Assets) | - | - | - | - | 10.1% | 11.1% | - |
| Assets 1 | - | - | - | - | 22,851 | 24,869 | - |
| Book Value Per Share 2 | - | 6.400 | 6.750 | 7.790 | 8.810 | 10.10 | 11.40 |
| Cash Flow per Share 2 | - | 0.1400 | 0.8700 | 1.350 | 1.620 | 2.020 | 1.670 |
| Capex 1 | - | 294 | 404 | 553 | 450 | 392 | 50 |
| Capex / Sales | - | 4.19% | 4.44% | 4.83% | 3.18% | 2.31% | 0.25% |
| Announcement Date | 4/19/21 | 4/25/22 | 4/26/23 | 4/25/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
34.3
CNY
Average target price
35.25
CNY
Spread / Average Target
+2.77%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +67.32% | 6.69B | |
| +24.18% | 3.47B | |
| -6.31% | 3.32B | |
| -10.59% | 2.13B | |
| -18.07% | 2.14B | |
| +6.57% | 1.92B | |
| +12.23% | 1.08B | |
| -22.76% | 1.09B | |
| +83.93% | 957M | |
| -16.43% | 933M |
- Stock Market
- Equities
- 601567 Stock
- Financials Ningbo Sanxing Medical Electric Co.,Ltd.